NRXCF - NeutriSci International Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
120
83
151
125
Cost of Revenue
117
79
162
100
Gross Profit
3
4
-11
25
Operating Expenses
Research Development
-
-
-
-
Selling General and Administrative
1,749
2,059
2,072
2,571
Total Operating Expenses
1,861
2,280
2,083
2,611
Operating Income or Loss
-1,858
-2,276
-2,093
-2,586
Interest Expense
-
1
29
61
Total Other Income/Expenses Net
-105
-106
0
82
Income Before Tax
-1,964
-2,383
-2,122
-2,565
Income Tax Expense
-
-
-
-
Income from Continuing Operations
-1,964
-2,383
-2,122
-2,565
Net Income
-1,964
-2,383
-2,122
-2,565
Net Income available to common shareholders
-1,964
-2,383
-2,122
-2,565
Reported EPS
Basic
-
-0.02
-0.03
-0.04
Diluted
-
-0.02
-0.03
-0.04
Weighted average shares outstanding
Basic
-
101,661
81,834
59,982
Diluted
-
101,661
81,834
59,982
EBITDA
-
-2,362
-2,083
-2,488